CD14-independent responses induced by a synthetic lipid a mimetic

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 797-802

  Legat, Amandine ^a   Thomas, Séverine ^a   Hermand, Philippe ^b   Van Mechelen, Marcelle ^b   Goldman, Michel ^a   De Wit, Dominique ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

CD14; Lipid A; TLR4

Indexed keywords

CD14 ANTIGEN; CRX 527; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; LIPID A; LIPID A DERIVATIVE; LIPOPOLYSACCHARIDE; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD14; BIOMIMETICS; CELL LINE; CYTOKINES; DENDRITIC CELLS; GLUCOSAMINE; HUMANS; LIPID A; LYMPHOCYTE ANTIGEN 96; MICE; MICE, INBRED C57BL; ORGANOPHOSPHORUS COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 77749285660     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939992     Document Type: Article

References (15)

1. Alderson, M. R., McGowan, P., Baldridge, J. R. and Probst, P., TLR4 agonists as immunomodulatory agents. J. Endotoxin. Res. 2006. 12: 313-319.
2. Johnson, D. A., Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics. Curr. Top. Med. Chem. 2008. 8: 64-79.
3. Lembo, A., Pelletier, M., Iyer, R., Timko, M., Dudda, J. C., West, T. E., Wilson, C. B. et al., Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. J. Immunol. 2008. 180: 7574-7581.
4. Baldridge, J. R., Cluff, C. W., Evans, J. T., Lacy, M. J., Stephens, J. R., Brookshire, V. G., Wang, R. et al., Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529. J. Endotoxin. Res. 2002. 8: 453-458.
5. Stover, A. G., Da Silva, C. J., Evans, J. T., Cluff, C.W., Elliott, M.W., Jeffery, E. W., Johnson, D. A. et al., Structure-activity relationship of synthetic toll-like receptor 4 agonists. J. Biol. Chem. 2004. 279: 4440-4449.
6. Fitzgerald, K. A., Rowe, D. C. and Golenbock, D. T., Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes. Infect. 2004. 6: 1361-1367.
7. Miyake, K., Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 2004. 12: 186-192.
8. Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M. et al., CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005. 6: 565-570.
9. Dauphinee, S. M. and Karsan, A., Lipopolysaccharide signaling in endothelial cells. Lab Invest. 2006. 86: 9-22.
10. Asai, Y., Makimura, Y., Kawabata, A. and Ogawa, T., Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation. J. Immunol. 2007. 179: 7674-7683.
11. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
12. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O. et al., Role of adaptor TRIF in the MyD88-independent tolllike receptor signaling pathway. Science 2003. 301: 640-643.
13. Duchow, J., Marchant, A., Crusiaux, A., Husson, C., Alonso-Vega, C., De Groote, D., Neve, P. et al., Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria. Infect. Immun. 1993. 61: 4280-4285.
14. Evans, J. T., Cluff, C. W., Johnson, D. A., Lacy, M. J., Persing, D. H. and Baldridge, J. R., Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi 529. Expert. Rev. Vaccines 2003. 2: 219-229.
15. Reed, S. G., Bertholet, S., Coler, R. N. and Friede, M., New horizons in adjuvants for vaccine development. Trends Immunol. 2009. 30: 23-32.